Only the right has signed this so far (Bill Ranking)
H.R. 498 · 119th Congress (2025-2026)
7 members · Left 0 · Center 0 · Right 7 (Bill Ranking)
| Sponsor | Rep. Crenshaw, Dan (R-TX) (Introduced 01/16/2025) |
|---|---|
| Sponsor Voting Record | Lean right · DW-NOMINATE +0.44 · measured from every roll-call vote this member has cast (voteview.com) (Sponsor Ranking) |
| Support |
LLLCLRR support across the spectrum: 7 members signed on (Bill Ranking) this bill: sponsor + current cosponsors, each once |
| Committees | Senate - Finance Committee; House - Energy and Commerce Committee; House - Energy and Commerce Committee; House - Energy and Commerce Committee |
| Latest Action | 12/18/2025 Received in the Senate and Read twice and referred to the Committee on Finance. |
| Roll Call Votes | 2 |
| Source | view on congress.gov → |
Introduced in House (01/16/2025)
Do No Harm in Medicaid Act
This bill prohibits federal Medicaid payment for specified gender transition procedures for individuals under the age of 18. The bill defines these procedures to mean those that are intended to change the body of an individual to no longer correspond to the individual's biological sex (male or female), including specified surgeries, implants, and medications (e.g., hormones).
The bill excludes procedures that are provided to an individual under the age of 18 with the consent of a parent or legal guardian and that are intended to (1) rectify early puberty, genetic disorders, or chromosomal abnormalities; (2) reverse prior gender transition procedures; or (3) prevent imminent death or impairment of a major bodily function.
119 HR 498 EH: Do No Harm in Medicaid Act U.S. House of Representatives text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS1st Session H. R. 498
IN THE HOUSE OF REPRESENTATIVES AN ACT To amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for gender transition procedures for minors.
1.Short titleThis Act may be cited as the Do No Harm in Medicaid Act.
2.Prohibiting federal medicaid funding for gender transition for minors (a)In generalSection 1903(i) of the Social Security Act (42 U.S.C. 1396b(i)) is amended— (1)in paragraph (26), by striking ; or and inserting a semicolon; (2)in paragraph (27), by striking the period at the end and inserting ; or; and (3)by inserting after paragraph (27) the following new paragraph: (28) with respect to any amount expended for specified gender procedures under section 1905(kk) to an individual under 18 years of age enrolled in a State plan (or waiver of such plan), including any amounts expended for the administration of a State program that furnishes specified procedures and drugs to individuals under 18 years of age.. (4)in the flush left matter at the end, by striking and (18), and inserting (18), and (28). (b)Prohibiting federal medicaid funding for gender transitions for minorsSection 1905 of the Social Security Act (42 U.S.C. 1396d) is amended by adding at the end the following new subsection: (KK)Prohibiting federal medicaid funding for gender transitions for minors (A)For purposes of section 1903(i)(28), except as provided in subparagraph (B), the term specified gender transition procedures means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual (including by disrupting the body’s development, inhibiting its natural functions, or modifying its appearance) to no longer correspond to the individual’s sex: (i)Performing any surgery, including— (I)castration; (II)sterilization; (III)orchiectomy; (IV)scrotoplasty; (V)vasectomy; (VI)tubal ligation; (VII)hysterectomy; (VIII)oophorectomy; (IX)ovariectomy; (X)metoidioplasty; (XI)clitoroplasty; (XII)reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty; (XIII)penectomy; (XIV)phalloplasty; (XV)vaginoplasty; (XVI)vaginectomy; (XVII)vulvoplasty; (XVIII)reduction thyrochondroplasty; (XIX)chondrolaryngoplasty; (XX)mastectomy; and (XXI)any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual. (ii)Any placement of chest implants to create feminine breasts or any placement of erection or testicular prosetheses. (iii)Any placement of fat or artificial implants in the gluteal region. (iv)Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including— (I)gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and (II)testosterone, estrogen, progesterone or other androgens to an individual at doses that are supraphysiologic, greater or more potent than would normally be produced endogenously in a healthy individual of the same age and sex. (B)ExceptionSubparagraph (A) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual’s parent or legal guardian: (i)Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty. (ii)Appropriate and medically necessary procedures or treatments to correct for— (I)a medically verifiable genetic disorder of sex development, including— (aa)46,XX chromosomes with virilization; (bb)46,XY chromosome with undervirilization; and (cc)both ovarian and testicular tissue; (II)sex chromosome structure, sexsteroid hormone production, or sex hormone action, if determined to be abnormal for a healthy individual of the same sex and age by a physician through genetic or biochemical testing; (III)infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in subparagraph (A), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress; or (IV)procedures to restore or reconstruct the body of the individual in order to correspond to the individual’s sex after one or more previous procedures described in subparagraph (A), which may include the removal of a pseudo phallus or breast augmentation. (C)SexFor purposes of subparagraph(A), the term sex means either male or female, as biologically determined and defined by clause (i) and clause (ii). (i)FemaleThe term female means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (ii)MaleThe term male means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization.. Passed the House of Representatives December 18, 2025.Kevin F. McCumber,Clerk.
119 HR 498 IH: Do No Harm in Medicaid Act U.S. House of Representatives 2025-01-16 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I119th CONGRESS1st SessionH. R. 498IN THE HOUSE OF REPRESENTATIVESJanuary 16, 2025Mr. Crenshaw (for himself and Ms. Greene of Georgia) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for gender transition procedures for minors.1.Short titleThis Act may be cited as the Do No Harm in Medicaid Act.2.Prohibiting federal medicaid funding for gender transition for minors(a)In generalSection 1903(i) of the Social Security Act (42 U.S.C. 1396b(i)) is amended—(1)in paragraph (26), by striking ; or and inserting a semicolon;(2)in paragraph (27), by striking the period at the end and inserting ; or; and(3)by inserting after paragraph (27) the following new paragraph: (28) with respect to any amount expended for specified gender procedures under section 1905(kk) to an individual under 18 years of age enrolled in a State plan (or waiver of such plan), including any amounts expended for the administration of a State program that furnishes specified procedures and drugs to individuals under 18 years of age..(4)in the flush left matter at the end, by striking and (18), and inserting (18), and (28).(b)Prohibiting federal medicaid funding for gender transitions for minorsSection 1905 of the Social Security Act (42 U.S.C. 1396d) is amended by adding at the end the following new subsection:(KK)Prohibiting federal medicaid funding for gender transitions for minors(A)For purposes of section 1903(i)(28), except as provided in subparagraph (B), the term specified gender transition procedures means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual (including by disrupting the body’s development, inhibiting its natural functions, or modifying its appearance) to no longer correspond to the individual’s sex:(i)Performing any surgery, including—(I)castration;(II)sterilization;(III)orchiectomy;(IV)scrotoplasty;(V)vasectomy;(VI)tubal ligation;(VII)hysterectomy;(VIII)oophorectomy;(IX)ovariectomy;(X)metoidioplasty;(XI)clitoroplasty;(XII)reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty;(XIII)penectomy;(XIV)phalloplasty;(XV)vaginoplasty;(XVI)vaginectomy;(XVII)vulvoplasty;(XVIII)reduction thyrochondroplasty;(XIX)chondrolaryngoplasty;(XX)mastectomy; and(XXI)any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual.(ii)Any placement of chest implants to create feminine breasts or any placement of erection or testicular prosetheses.(iii)Any placement of fat or artificial implants in the gluteal region.(iv)Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including—(I)gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and(II)testosterone, estrogen, progesterone or other androgens to an individual at doses that are supraphysiologic, greater or more potent than would normally be produced endogenously in a healthy individual of the same age and sex.(B)ExceptionSubparagraph (A) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual’s parent or legal guardian:(i)Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty.(ii)Appropriate and medically necessary procedures or treatments to correct for—(I)a medically verifiable genetic disorder of sex development, including—(aa)46,XX chromosomes with virilization;(bb)46,XY chromosome with undervirilization; and(cc)both ovarian and testicular tissue;(II)sex chromosome structure, sexsteroid hormone production, or sex hormone action, if determined to be abnormal for a healthy individual of the same sex and age by a physician through genetic or biochemical testing;(III)infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in subparagraph (A), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress; or(IV)procedures to restore or reconstruct the body of the individual in order to correspond to the individual’s sex after one or more previous procedures described in subparagraph (A), which may include the removal of a pseudo phallus or breast augmentation.(C)SexFor purposes of subparagraph(A), the term sex means either male or female, as biologically determined and defined by clause (i) and clause (ii).(i)FemaleThe term female means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.(ii)MaleThe term male means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization..
119 HR 498 : Do No Harm in Medicaid Act U.S. House of Representatives 2025-12-18 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IIB119th CONGRESS1st SessionH. R. 498IN THE SENATE OF THE UNITED STATESDecember 18, 2025Received; read twice and referred to the Committee on FinanceAN ACTTo amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for gender transition procedures for minors.1.Short titleThis Act may be cited as the Do No Harm in Medicaid Act.2.Prohibiting federal medicaid funding for gender transition for minors(a)In generalSection 1903(i) of the Social Security Act (42 U.S.C. 1396b(i)) is amended—(1)in paragraph (26), by striking ; or and inserting a semicolon;(2)in paragraph (27), by striking the period at the end and inserting ; or; and(3)by inserting after paragraph (27) the following new paragraph: (28) with respect to any amount expended for specified gender procedures under section 1905(kk) to an individual under 18 years of age enrolled in a State plan (or waiver of such plan), including any amounts expended for the administration of a State program that furnishes specified procedures and drugs to individuals under 18 years of age..(4)in the flush left matter at the end, by striking and (18), and inserting (18), and (28).(b)Prohibiting federal medicaid funding for gender transitions for minorsSection 1905 of the Social Security Act (42 U.S.C. 1396d) is amended by adding at the end the following new subsection:(KK)Prohibiting federal medicaid funding for gender transitions for minors(A)For purposes of section 1903(i)(28), except as provided in subparagraph (B), the term specified gender transition procedures means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual (including by disrupting the body’s development, inhibiting its natural functions, or modifying its appearance) to no longer correspond to the individual’s sex:(i)Performing any surgery, including—(I)castration;(II)sterilization;(III)orchiectomy;(IV)scrotoplasty;(V)vasectomy;(VI)tubal ligation;(VII)hysterectomy;(VIII)oophorectomy;(IX)ovariectomy;(X)metoidioplasty;(XI)clitoroplasty;(XII)reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty;(XIII)penectomy;(XIV)phalloplasty;(XV)vaginoplasty;(XVI)vaginectomy;(XVII)vulvoplasty;(XVIII)reduction thyrochondroplasty;(XIX)chondrolaryngoplasty;(XX)mastectomy; and(XXI)any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other physiological features of an individual.(ii)Any placement of chest implants to create feminine breasts or any placement of erection or testicular prosetheses.(iii)Any placement of fat or artificial implants in the gluteal region.(iv)Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including—(I)gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and(II)testosterone, estrogen, progesterone or other androgens to an individual at doses that are supraphysiologic, greater or more potent than would normally be produced endogenously in a healthy individual of the same age and sex.(B)ExceptionSubparagraph (A) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual’s parent or legal guardian:(i)Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty.(ii)Appropriate and medically necessary procedures or treatments to correct for—(I)a medically verifiable genetic disorder of sex development, including—(aa)46,XX chromosomes with virilization;(bb)46,XY chromosome with undervirilization; and(cc)both ovarian and testicular tissue;(II)sex chromosome structure, sexsteroid hormone production, or sex hormone action, if determined to be abnormal for a healthy individual of the same sex and age by a physician through genetic or biochemical testing;(III)infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in subparagraph (A), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress; or(IV)procedures to restore or reconstruct the body of the individual in order to correspond to the individual’s sex after one or more previous procedures described in subparagraph (A), which may include the removal of a pseudo phallus or breast augmentation.(C)SexFor purposes of subparagraph(A), the term sex means either male or female, as biologically determined and defined by clause (i) and clause (ii).(i)FemaleThe term female means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.(ii)MaleThe term male means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization..Passed the House of Representatives December 18, 2025.Kevin F. McCumber,Clerk.
The bill's own words, from our database (synced from the GPO BILLS XML); paragraph breaks added at the bill's section boundaries, nothing else changed.
| Date | Chamber | All Actions |
|---|---|---|
| 01/16/2025 | Library of Congress | Introduced in House |
| 01/16/2025 | Library of Congress | Introduced in House |
| 01/16/2025 | House floor actions | Referred to the House Committee on Energy and Commerce. |
| 12/17/2025 | House floor actions | Rules Committee Resolution H. Res. 953 Reported to House. Rule provides for consideration of H.R. 6703, H.R. 498 and H.R. 3492. The resolution provides for consideration of H.R. 6703 and H.R. 498 under a closed rule and H.R. 3492 under a structured rule with one hour of general debate and one motion to recommit on each bill. |
| 12/18/2025 | House floor actions | Considered under the provisions of rule H. Res. 953. (consideration: CR H6057-6065) |
| 12/18/2025 | House floor actions | Rule provides for consideration of H.R. 6703, H.R. 498 and H.R. 3492. The resolution provides for consideration of H.R. 6703 and H.R. 498 under a closed rule and H.R. 3492 under a structured rule with one hour of general debate and one motion to recommit on each bill. |
| 12/18/2025 | House floor actions | DEBATE - The House proceeded with one hour of debate on H.R. 498. |
| 12/18/2025 | House floor actions | The previous question was ordered pursuant to the rule. |
| 12/18/2025 | House floor actions | Mr. Soto moved to recommit to the Committee on Energy and Commerce. (text: CR H6065) |
| 12/18/2025 | House floor actions | The previous question on the motion to recommit was ordered pursuant to clause 2(b) of rule XIX. |
| 12/18/2025 | House floor actions | POSTPONED PROCEEDINGS - At the conclusion of debate on H.R. 498, the Chair put the question on motion to recommit and by voice vote announced that the noes had prevailed. Mr. Soto demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced. |
| 12/18/2025 | House floor actions | Considered as unfinished business. (consideration: CR H6072-6073) |
| 12/18/2025 | House floor actions | On motion to recommit Failed by the Yeas and Nays: 204 - 212 (Roll no. 361). |
| 12/18/2025 | Library of Congress | Passed/agreed to in House: On passage Passed by the Yeas and Nays: 215 - 201 (Roll no. 362). |
| 12/18/2025 | House floor actions | On passage Passed by the Yeas and Nays: 215 - 201 (Roll no. 362). (text: CR H6057) |
| 12/18/2025 | House floor actions | Motion to reconsider laid on the table Agreed to without objection. |
| 12/18/2025 | Senate | Received in the Senate and Read twice and referred to the Committee on Finance. |
| Title Type | Title |
|---|---|
| Short Titles from RFS (Referred to Senate) bill text | Do No Harm in Medicaid Act |
| Short Title(s) as Passed House | Do No Harm in Medicaid Act |
| Official Titles from EH (Engrossed in House) bill text | To amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for gender transition procedures for minors. |
| Display Title | Do No Harm in Medicaid Act |
| Short Title(s) as Introduced | Do No Harm in Medicaid Act |
| Official Title as Introduced | To amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for gender transition procedures for minors. |
There are no amendments to this bill.
* = Original cosponsor
| Committee | Activity |
|---|---|
| Senate - Finance Committee | 12/18/2025 Referred To |
| House - Energy and Commerce Committee | 12/18/2025 Unknown |
| House - Energy and Commerce Committee | 12/18/2025 Unknown |
| House - Energy and Commerce Committee | 01/16/2025 Referred To |
Policy Area: Health
All data on this page comes from our own database (legislation.congress_* tables), synced daily from the GPO govinfo BILLSTATUS and BILLS collections. Formatted after congress.gov; nothing is generated. Member placement is their DW-NOMINATE score (voteview.com, Lewis et al.) - a measurement of roll-call voting behavior, not our judgement. Buckets: Left below −0.50 · Lean Left to −0.25 · Center to +0.25 · Lean Right to +0.50 · Right above +0.50. The bill's Support meter aggregates the people who signed the bill - sponsor and current cosponsors, each counted once - nothing else.